Author:
Ameline A.,Blanchot A.,Arbouche N.,Strebler J.,Raul J.-S.,Kintz P.
Subject
Pathology and Forensic Medicine
Reference32 articles.
1. Transdermal scopolamine for prevention of motion sickness. Clinical pharmacokinetics and therapeutic application;Nachum;Clin Pharmacokinet,2006
2. Pharmacokinetics and pharmacodynamics in clinical use of scopolamine;Renner;Ther Drug Monit,2005
3. SCOPODERM TTS 1mg/72heures, dispositif transdermique - Résumé des caractéristiques du produit. Base de données publique des médicaments. Document consulté le 16 mars 2021, sur le site http://base-donnees-publique.medicaments.gouv.fr/affichageDoc.php?specid=63958849&typedoc=R.
4. Muscarinic receptor agonists and antagonists;Broadley;Molecules,2001
5. Unique scopolamine withdrawal dyndrome after standard transdermal use;Manno;Clin Neuropharmacol,2015
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Scopolamine;Reactions Weekly;2021-11